However, the majority of T-ALL and other malignancies originating from BCL11B-positive tissues, such as head and neck squamous cell carcinomas (HNSCC), Ewing sarcomas or neuroblastomas (NBs) are characterized by elevated expression of non-altered gene ([21,22], unpublished observation). This evidence concerns the gene BCL11B and acute lymphoblastic leukemia.